On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Diabetes management has come a long way, with treatment options now as varied as they are effective. No longer limited to ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with a new kind of pump technology in the Twiist device.

Analyst Jeff Johnson from Robert W. Baird maintained a Buy rating on Insulet (PODD – Research Report) and keeping the price target at ...

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...